CK-MB Test: Normal Ranges, High Levels & Heart Attack Diagn…

Q: Why has troponin replaced CK-MB as the primary cardiac biomarker?

Cardiac troponins (cTnI and cTnT) are more sensitive and more specific for myocardial injury than CK-MB. Troponin is detectable earlier with high-sensitivity assays, remains elevated longer (up to 2 weeks), and is not significantly elevated by skeletal muscle injury. CK-MB retains value for detecting reinfarction and timing of injury due to its faster normalization (48–72 hours vs. 1–2 weeks for troponin).

Q: What is the CK-MB relative index?

The CK-MB relative index is calculated as (CK-MB / total CK) × 100. A ratio >5% suggests that the CK-MB elevation is primarily from cardiac muscle rather than skeletal muscle. This is helpful when both total CK and CK-MB are elevated, as occurs in rhabdomyolysis with concurrent cardiac injury.

CK-MB

Cardíaco

Última revisão: 7 de abril de 2026. Abordagem de fontes: contexto padrão de interpretação laboratorial, material médico de referência e orientações clínicas ou de saúde pública quando relevantes.

O que é CK-MB?

CK-MB (creatine kinase-MB isoenzyme) is one of three isoenzymes of creatine kinase (CK), an enzyme that catalyzes the reversible transfer of phosphate from creatine phosphate to ADP, generating ATP for cellular energy. The three CK isoenzymes differ in their tissue distribution: CK-MM predominates in skeletal muscle, CK-BB in brain and smooth muscle, and CK-MB in cardiac muscle (comprising approximately 20–30% of total cardiac CK, compared to 1–3% of skeletal muscle CK). Because of its relative cardiac specificity, CK-MB was historically the gold-standard biomarker for diagnosing acute myocardial infarction (AMI).

While high-sensitivity cardiac troponins (hs-cTnI and hs-cTnT) have largely replaced CK-MB as the preferred biomarker for AMI diagnosis due to their superior sensitivity and specificity, CK-MB retains important clinical roles. Its faster rise-and-fall kinetics (rises within 3–6 hours, peaks at 12–24 hours, and normalizes within 48–72 hours) make it useful for detecting reinfarction in the early post-MI period, when troponin levels may still be elevated from the index event. CK-MB is also used to assess infarct size and timing, evaluate periprocedural myocardial injury after PCI or CABG, and in some settings where troponin assays are unavailable.

Por que isso importa

CK-MB was the cornerstone of myocardial infarction diagnosis for decades and remains clinically relevant in specific scenarios. Its faster clearance compared to troponin makes it particularly useful for detecting reinfarction—a second rise in CK-MB after initial normalization is a reliable indicator of a new myocardial injury event when troponin levels remain elevated from the first event. CK-MB mass (measured by immunoassay) has largely replaced CK-MB activity for better sensitivity. The CK-MB relative index (CK-MB/total CK × 100) helps distinguish cardiac from skeletal muscle CK-MB release: a ratio >5% suggests myocardial origin.

Faixas de referência normais

Grupo	Faixa	Unidade
Adults (CK-MB mass)	0–5	ng/mL
CK-MB relative index	<5%	(CK-MB/total CK × 100)

As faixas de referência podem variar entre laboratórios. Sempre compare seus resultados com as faixas fornecidas pelo seu local de exame.

O que significam níveis altos de CK-MB

Causas comuns

Acute myocardial infarction
Myocarditis
Cardiac surgery (CABG, valve surgery)
Percutaneous coronary intervention (periprocedural injury)
Cardiac contusion (blunt chest trauma)
Severe skeletal muscle injury or rhabdomyolysis (CK-MB from skeletal muscle)
Muscular dystrophies (chronic skeletal muscle disease)
Strenuous exercise (particularly endurance athletes)
Electrical cardioversion or defibrillation

Possíveis sintomas

Chest pain or pressure
Shortness of breath
Diaphoresis (sweating)
Nausea
Pain radiating to arm, jaw, or back
Dizziness or lightheadedness
Palpitations

O que fazer: Elevated CK-MB in the setting of chest pain and ECG changes requires urgent cardiology evaluation for acute myocardial infarction. Obtain serial measurements (0, 3–6, and 12 hours) to document the rise-and-fall pattern characteristic of MI. Concurrently measure troponin, which is the preferred primary biomarker. Calculate the CK-MB relative index to distinguish cardiac from skeletal muscle sources. If CK-MB is elevated without troponin elevation, consider skeletal muscle injury. In post-MI patients, a secondary rise in CK-MB after initial normalization suggests reinfarction and requires immediate reevaluation.

O que significam níveis baixos de CK-MB

Causas comuns

Normal result—no myocardial injury detected
Low muscle mass

Possíveis sintomas

No symptoms associated with low CK-MB

O que fazer: Low or undetectable CK-MB is normal and expected. In the evaluation of chest pain, CK-MB should not be used as the sole biomarker—high-sensitivity cardiac troponin is the preferred test. A normal CK-MB within the first 6 hours of symptom onset does not exclude MI, and serial measurements or troponin should be used.

Quando o exame de CK-MB é recomendado?

Suspected acute myocardial infarction (alongside troponin)
Detecting reinfarction when troponin is still elevated from initial event
Evaluating periprocedural myocardial injury after PCI or CABG
Assessment of myocardial infarct size and timing
When high-sensitivity troponin assays are unavailable

Perguntas frequentes

Cardiac troponins (cTnI and cTnT) are more sensitive and more specific for myocardial injury than CK-MB. Troponin is detectable earlier with high-sensitivity assays, remains elevated longer (up to 2 weeks), and is not significantly elevated by skeletal muscle injury. CK-MB retains value for detecting reinfarction and timing of injury due to its faster normalization (48–72 hours vs. 1–2 weeks for troponin).

The CK-MB relative index is calculated as (CK-MB / total CK) × 100. A ratio >5% suggests that the CK-MB elevation is primarily from cardiac muscle rather than skeletal muscle. This is helpful when both total CK and CK-MB are elevated, as occurs in rhabdomyolysis with concurrent cardiac injury.

Yes. Intense or prolonged exercise, particularly marathon running and other endurance sports, can elevate CK-MB from skeletal muscle. Skeletal muscle contains small amounts (1–3%) of CK-MB, and massive muscle breakdown can produce significant CK-MB elevations. In exercise-related elevations, the CK-MB relative index is typically <5%, helping distinguish it from cardiac injury.

Biomarcadores relacionados

BNPB-Type Natriuretic Peptide / NT-proBNP LDHLactate Dehydrogenase

Referências e abordagem de revisão

As páginas do glossário de biomarcadores são explicações educativas e devem ser interpretadas junto com as faixas de referência e observações fornecidas pelo seu laboratório e pelo seu médico. Para conhecer nossos padrões editoriais e processo de revisão, veja nossa Política editorial e a nossa revisão de conteúdo.

Quer analisar seus níveis de CK-MB?

Envie seus resultados de exames para receber uma análise instantânea com IA de todos os seus biomarcadores.

Enviar resultados de exames →

Aviso médico: Estas informações são apenas educativas e não substituem orientação, diagnóstico ou tratamento médico profissional. As faixas de referência podem variar entre laboratórios. Sempre converse com seu profissional de saúde sobre a interpretação dos seus resultados específicos.